Correlation Between NLS Pharmaceutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Puma Biotechnology, you can compare the effects of market volatilities on NLS Pharmaceutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Puma Biotechnology.
Diversification Opportunities for NLS Pharmaceutics and Puma Biotechnology
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between NLS and Puma is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Puma Biotechnology
Assuming the 90 days horizon NLS Pharmaceutics is expected to generate 1.56 times less return on investment than Puma Biotechnology. In addition to that, NLS Pharmaceutics is 3.16 times more volatile than Puma Biotechnology. It trades about 0.04 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.2 per unit of volatility. If you would invest 279.00 in Puma Biotechnology on December 4, 2024 and sell it today you would earn a total of 60.00 from holding Puma Biotechnology or generate 21.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NLS Pharmaceutics AG vs. Puma Biotechnology
Performance |
Timeline |
NLS Pharmaceutics |
Puma Biotechnology |
NLS Pharmaceutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NLS Pharmaceutics and Puma Biotechnology
The main advantage of trading using opposite NLS Pharmaceutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |